INFI

Infinity Pharmaceuticals, Inc.
INFI

Overview Fund Activity
Delisted

INFI was delisted on the 13th of September, 2023.

Back to rankings

51 hedge funds and large institutions have $30.2M invested in Infinity Pharmaceuticals, Inc. in 2019 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 16 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
51
Holders Change
-4
Holders Change %
-7.27%
% of All Funds
1.12%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
3
Increased
6
Reduced
16
Closed
7
Calls
$37K
Puts
–
Net Calls
+$37K
Net Calls Change
-$43K

Top Buyers

1
Renaissance Technologies
Renaissance Technologies
New York
+$123K
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$19.9K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$11K
4
Victory Capital Management
Victory Capital Management
Texas
+$10K
5
TRCT
Tower Research Capital (TRC)
New York
+$3K

Top Sellers

1
First Eagle Investment Management
First Eagle Investment Management
New York
-$900K
2
FI
Fosun International
China
-$728K
3
AC
Athanor Capital
New York
-$90.2K
4
PPA
Parametric Portfolio Associates
Washington
-$76K
5
OAM
Oxford Asset Management
United Kingdom
-$54.6K
Name Holding Trade Value Shares
Change 		Shares
Change %
First Eagle Investment Management
51
First Eagle Investment Management
New York
– -$900K -500,000 Closed
FI
52
Fosun International
China
– -$728K -418,296 Closed
PPA
53
Parametric Portfolio Associates
Washington
– -$76K -42,114 Closed
PAM
54
Panagora Asset Management
Massachusetts
– -$54K -29,790 Closed
TSS
55
Two Sigma Securities
New York
– -$29K -15,942 Closed
AG
56
Aperio Group
California
– -$2K -994 Closed
GAM
57
Griffin Asset Management
New York
– -$1K -700 Closed
1 2
3